Shares of Danaher Corporation (NYSE:DHR – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-five ratings firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $233.6087.
Several equities research analysts have recently commented on DHR shares. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a research note on Friday, April 17th. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Wells Fargo & Company dropped their price target on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. Evercore raised their price objective on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 21st. Finally, TD Cowen decreased their target price on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd.
View Our Latest Analysis on Danaher
Institutional Trading of Danaher
Danaher Stock Performance
DHR opened at $193.81 on Thursday. The company has a market cap of $137.17 billion, a P/E ratio of 37.49, a price-to-earnings-growth ratio of 2.43 and a beta of 0.79. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The firm’s 50-day moving average price is $178.68 and its 200-day moving average price is $200.76. Danaher has a 52-week low of $160.93 and a 52-week high of $242.80.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. Danaher’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period last year, the business earned $1.88 EPS. As a group, equities analysts anticipate that Danaher will post 8.44 EPS for the current fiscal year.
Danaher Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
